Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction

IMPORTANCE: Sacubitril-valsartan use reduces mortality and hospitalizations compared with enalapril among patients with chronic heart failure with reduced ejection fraction (HFrEF); however, the cost-effectiveness of these treatments when initiated during hospitalization for HF is unknown. OBJECTIVE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Gaziano, Thomas A., Fonarow, Gregg C., Velazquez, Eric J., Morrow, David A., Braunwald, Eugene, Solomon, Scott D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675099/
https://ncbi.nlm.nih.gov/pubmed/32785628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.2822
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados